THERO JOHN F 4
4 · Cyteir Therapeutics, Inc. · Filed Feb 12, 2024
Insider Transaction Report
Form 4
THERO JOHN F
Director
Transactions
- Exercise/Conversion
Common Stock
2024-02-08$1.69/sh+12,828$21,679→ 22,828 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-02-08−12,828→ 0 totalExercise: $1.69From: 2024-02-03Exp: 2033-02-03→ Common Stock (12,828 underlying)